These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 6813489
1. Mechanisms of action of auranofin: effects on humoral immune response. Walz DT, Dimartino MJ, Griswold DE. J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489 [Abstract] [Full Text] [Related]
2. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity. Walz DT, DiMartino MJ, Griswold DE. J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651 [Abstract] [Full Text] [Related]
3. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats. Walz DT, Griswold DE, DiMartino MJ, Bumbier EE. J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031 [Abstract] [Full Text] [Related]
4. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats. Garrett IR, Whitehouse MW, Vernon-Roberts B, Brooks PM. J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896 [Abstract] [Full Text] [Related]
5. Biologic actions and pharmacokinetic studies of auranofin. Walz DT, DiMartino MJ, Griswold DE, Intoccia AP, Flanagan TL. Am J Med; 1983 Dec 30; 75(6A):90-108. PubMed ID: 6318557 [Abstract] [Full Text] [Related]
6. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis. Harth M, McCain GA, Orange JF. J Rheumatol; 1985 Oct 30; 12(5):881-4. PubMed ID: 3936929 [Abstract] [Full Text] [Related]
7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts]. Chamouard JM, Clerc D, Bisson M, Medicis P, Massias P. Rev Rhum Mal Osteoartic; 1985 Apr 30; 52(4):277-82. PubMed ID: 3923604 [No Abstract] [Full Text] [Related]
12. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity. Russell AS, Davis P, Miller C. J Rheumatol; 1982 Apr 30; 9(1):30-5. PubMed ID: 6806471 [Abstract] [Full Text] [Related]
13. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. Edelman J, Davis P, Owen ET. J Rheumatol; 1983 Feb 30; 10(1):121-3. PubMed ID: 6405032 [Abstract] [Full Text] [Related]
14. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties]. Batlle Gualda E. Med Clin (Barc); 1985 May 25; 84(20):834-9. PubMed ID: 3928990 [No Abstract] [Full Text] [Related]
15. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action. Wolach B, DeBoard JE, Coates TD, Baehner RL, Boxer LA. J Lab Clin Med; 1982 Jul 25; 100(1):37-44. PubMed ID: 6283001 [Abstract] [Full Text] [Related]
16. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin. Hashimoto K, Whitehurst CE, Lipsky PE. J Rheumatol; 1994 Jun 25; 21(6):1020-6. PubMed ID: 7932408 [Abstract] [Full Text] [Related]